Thermo Fisher Scientific Inc (TMO)

Return on total capital

Dec 31, 2025 Sep 30, 2025 Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Earnings before interest and tax (EBIT) (ttm) US$ in thousands 8,513,000 8,537,000 8,528,000 8,602,000 8,630,000 8,488,000 8,480,000 8,049,000 7,761,000 7,623,000 7,239,000 7,548,000 8,561,000 8,538,000 9,065,000 9,169,000 9,371,000 10,388,000 10,483,000 9,704,000
Long-term debt US$ in thousands
Total stockholders’ equity US$ in thousands 53,415,000 51,024,000 50,511,000 49,390,000 49,584,000 48,992,000 47,432,000 45,516,000 46,735,000 45,328,000 43,752,000 42,257,000 43,978,000 43,549,000 42,293,000 40,956,000 40,793,000 38,710,000 36,854,000 35,058,000
Return on total capital 15.94% 16.73% 16.88% 17.42% 17.40% 17.33% 17.88% 17.68% 16.61% 16.82% 16.55% 17.86% 19.47% 19.61% 21.43% 22.39% 22.97% 26.84% 28.44% 27.68%

December 31, 2025 calculation

Return on total capital = EBIT (ttm) ÷ (Long-term debt + Total stockholders’ equity)
= $8,513,000K ÷ ($—K + $53,415,000K)
= 15.94%


Peer comparison

Dec 31, 2025

Company name
Symbol
Return on total capital
Thermo Fisher Scientific Inc
TMO
15.94%
Agilent Technologies Inc
A
22.95%
Danaher Corporation
DHR
8.56%